Vaccinators' Perception of HPV Vaccination in the Saa Health District of Cameroon

Abstract

Introduction: Cervical cancer is the second most prevalent cancer among women in Cameroon. In November 2020, the HPV vaccine was introduced into the expanded programme on immunisation. However, uptake of the vaccine has been slow in the Centre region as opposed to other regions in the country. We therefore sought to describe vaccinators' perception of HPV vaccination in Saa health district.Methods: A self-administered questionnaire with both open-ended and closed questions was used to assess the perception of HPV vaccination among 24 vaccinators from the Saa health district. Quantitative data were summarised as proportions while qualitative data were deductively and inductively coded and thematically analysed.Results: Most vaccinators (75%, n = 18) had a good knowledge about cervical cancer and HPV vaccination. Fourteen (58.3%, n = 14) vaccinators correctly reported the target group, number and spacing of doses for the HPV vaccine. Fourteen (58.3%) vaccinators favoured HPV vaccination while the others (n = 10) were sceptical. Sceptics felt manufacturers hadn't given enough proof of the safety of the vaccine and lacked confidence in government's assessment of the epidemiological situation. The COVID 19 pandemic, fear of infertility and the negative influence of social media were perceived as the main reasons for community hesitancy. Vaccinators criticised health authorities for failing to sensitise the population about the HPV vaccine before its introduction.Conclusion: Vaccinators' perceptions of HPV vaccination may influence the offer of HPV vaccination services. Measures to increase acceptance of HPV vaccination and ownership of the activity among vaccinators have to be put in place.

Malaria Vaccine Introduction in Cameroon: Early Results 30 Days into Rollout

“…Cameroon is the first country to introduce the malaria vaccine into its routine immunization program outside the pilot program that was implemented in three countries (Ghana, Kenya, and Malawi). This introduction occurred after the ones for the Human Papillomavirus (HPV) vaccines in 2020 and COVID-19 vaccines in 2021 that resulted in a high vaccine hesitancy and low coverage [15][16][17][18]. Exposure to misinformation and a low risk perception were the main drivers of vaccine hesitancy in the case of COVID-19 and HPV vaccine in Cameroon.…”

Setting up a data system for monitoring malaria vaccine introduction readiness and uptake in 42 health districts in Cameroon

“…Cameroon experienced high vaccine hesitancy leading to low uptake during the recent introductions of human papillomavirus vaccines in 2019 and COVID-19 vaccines in 2021 20 21. Given the high burden of malaria in Africa and the expectations raised by the addition of malaria vaccines among response tools, considered a step forward towards malaria elimination, the malaria vaccine introduction attracted the attention of the media (figure 4).…”

Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective

“…Due to girls aged 9 to 14 not yet sexually involved, World Health Organization (WHO) suggested these ages as the most suitable time for vaccination against HPV ( 18 ). The national immunization schedules for young women before sexual activity significantly decreased HPV-associated mortality and will be affordable ( 19 ).…”